Jaundice differential diagnosis: Difference between revisions
No edit summary |
|||
Line 47: | Line 47: | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" |Viral serology | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" |Viral serology | ||
|- | |- | ||
! rowspan=" | ! rowspan="30" align="center" style="background:#4479BA; color: #FFFFFF;" |Jaundice | ||
! colspan="1" rowspan=" | ! colspan="1" rowspan="9" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Hepatocellular Jaundice | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hemochromatosis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Liver infiltration: Hemochromatosis, amyloidosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 60: | Line 60: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Ferritin ↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Ferritin ↑ in hemochromatosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | ||
|- | |- | ||
Line 147: | Line 147: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Small liver on ultrasond | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Small liver on ultrasond | ||
|- | |- | ||
! rowspan=" | !Nonalcoholic steatohepatitis | ||
!-/+ | |||
!- | |||
!- | |||
!- | |||
|↑ | |||
|↑ | |||
|N | |||
|↑/N | |||
|N | |||
| - | |||
!High lipids | |||
!liver biopsy | |||
|- | |||
!Ischemic hepatopathy | |||
!-/+ | |||
!- | |||
!-/+ | |||
!- | |||
|↑ | |||
|↑ | |||
|N | |||
|↑/N | |||
|N | |||
| - | |||
!Cardiovascular risk factors | |||
!Clinical setting | |||
|- | |||
! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Cholestatic Jaundice | |||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
Line 236: | Line 264: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/↑ | ||
Line 245: | Line 273: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT scan for diagnosis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT scan for diagnosis | ||
|- | |||
! AIDS cholangiopathy | |||
!- | |||
!- | |||
!-/+ | |||
!-/+ | |||
|N/↑ | |||
|N/↑ | |||
|↑ | |||
|N | |||
|↑ | |||
| - | |||
!Pos. HIV | |||
!Sono or ERCP for diagnosis | |||
|- | |||
!Parasites induces cholestasis | |||
!- | |||
!- | |||
!-/+ | |||
!-/+ | |||
|N/↑ | |||
|N/↑ | |||
|↑ | |||
|N | |||
|↑ | |||
| - | |||
!Ab or parasite serology | |||
!Sono or ERCP for diagnosis | |||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Intrahepatic cholestasis of pregnancy | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Intrahepatic cholestasis of pregnancy |
Revision as of 16:57, 19 December 2017
Jaundice Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Jaundice differential diagnosis On the Web |
American Roentgen Ray Society Images of Jaundice differential diagnosis |
Risk calculators and risk factors for Jaundice differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Jaundice is yellowish discoloration of the skin, conjunctiva, and mucous membranes caused by hyperbilirubinemia. Usually, the concentration of bilirubin in the blood must exceed 2–3 mg/dL for the coloration to be easily visible. This page contains different causes of jaundice.
Differential diagnosis of jaundice
The differential diagnosis for jaundice, click here.
The differential diagnosis for jaundice and RUQ pain, click here.
The differential diagnosis for jaundice and pruritis, click here.
The differential diagnosis for jaundice and fever, click here.
The differential diagnosis for jaundice, fever, and RUQ pain, click here.
The differential diagnosis for jaundice, pruritis and RUQ pain, click here.
Differential diagnosis of jaundice are: [1][2][3][4]
|
References
- ↑ Fargo MV, Grogan SP, Saguil A (2017). "Evaluation of Jaundice in Adults". Am Fam Physician. 95 (3): 164–168. PMID 28145671.
- ↑ Leevy CB, Koneru B, Klein KM (1997). "Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease". Gastroenterology. 113 (3): 966–72. PMID 9287990.
- ↑ Hov JR, Boberg KM, Karlsen TH (2008). "Autoantibodies in primary sclerosing cholangitis". World J. Gastroenterol. 14 (24): 3781–91. PMC 2721433. PMID 18609700.
- ↑ Bond LR, Hatty SR, Horn ME, Dick M, Meire HB, Bellingham AJ (1987). "Gall stones in sickle cell disease in the United Kingdom". Br Med J (Clin Res Ed). 295 (6592): 234–6. PMC 1247079. PMID 3115390.